These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31808062)

  • 1. Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age.
    Lahuerta M; Gonzalez D; Aguado C; Fathinajafabadi A; García-Giménez JL; Moreno-Estellés M; Romá-Mateo C; Knecht E; Pallardó FV; Sanz P
    Mol Neurobiol; 2020 Mar; 57(3):1607-1621. PubMed ID: 31808062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy.
    Rubio T; Viana R; Moreno-Estellés M; Campos-Rodríguez Á; Sanz P
    Neurobiol Dis; 2023 Jan; 176():105964. PubMed ID: 36526090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astrocytes: new players in progressive myoclonus epilepsy of Lafora type.
    Rubio-Villena C; Viana R; Bonet J; Garcia-Gimeno MA; Casado M; Heredia M; Sanz P
    Hum Mol Genet; 2018 Apr; 27(7):1290-1300. PubMed ID: 29408991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of Laforin and Other Related Proteins in Canine Lafora Disease With EPM2B Repeat Expansion.
    Chambers JK; Thongtharb A; Shiga T; Azakami D; Saito M; Sato M; Morozumi M; Nakayama H; Uchida K
    Vet Pathol; 2018 Jul; 55(4):543-551. PubMed ID: 29444631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress, a new hallmark in the pathophysiology of Lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Aguado C; García-Giménez JL; Knecht E; Sanz P; Pallardó FV
    Free Radic Biol Med; 2015 Nov; 88(Pt A):30-41. PubMed ID: 25680286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.
    Sullivan MA; Nitschke S; Steup M; Minassian BA; Nitschke F
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Sanz P; Gentry MS
    IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model.
    Mollá B; Heredia M; Campos Á; Sanz P
    Mol Neurobiol; 2022 Oct; 59(10):6018-6032. PubMed ID: 35835895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice.
    Nitschke S; Chown EE; Zhao X; Gabrielian S; Petković S; Guisso DR; Perri AM; Wang P; Ahonen S; Nitschke F; Minassian BA
    J Biol Chem; 2021; 296():100150. PubMed ID: 33277363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models.
    López-González I; Viana R; Sanz P; Ferrer I
    Mol Neurobiol; 2017 Jul; 54(5):3119-3130. PubMed ID: 27041370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease?
    Puri R; Ganesh S
    Autophagy; 2010 Nov; 6(8):1229-31. PubMed ID: 20818153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trehalose Ameliorates Seizure Susceptibility in Lafora Disease Mouse Models by Suppressing Neuroinflammation and Endoplasmic Reticulum Stress.
    Sinha P; Verma B; Ganesh S
    Mol Neurobiol; 2021 Mar; 58(3):1088-1101. PubMed ID: 33094475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lafora disease.
    Turnbull J; Tiberia E; Striano P; Genton P; Carpenter S; Ackerley CA; Minassian BA
    Epileptic Disord; 2016 Sep; 18(S2):38-62. PubMed ID: 27702709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model.
    Moreno-Estellés M; Campos-Rodríguez Á; Rubio-Villena C; Kumarasinghe L; Garcia-Gimeno MA; Sanz P
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease.
    Puri R; Suzuki T; Yamakawa K; Ganesh S
    Hum Mol Genet; 2012 Jan; 21(1):175-84. PubMed ID: 21965301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice.
    Ganesh S; Delgado-Escueta AV; Sakamoto T; Avila MR; Machado-Salas J; Hoshii Y; Akagi T; Gomi H; Suzuki T; Amano K; Agarwala KL; Hasegawa Y; Bai DS; Ishihara T; Hashikawa T; Itohara S; Cornford EM; Niki H; Yamakawa K
    Hum Mol Genet; 2002 May; 11(11):1251-62. PubMed ID: 12019206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for Lafora disease in the Epm2a
    Zafra-Puerta L; Iglesias-Cabeza N; Burgos DF; Sciaccaluga M; González-Fernández J; Bellingacci L; Canonichesi J; Sánchez-Martín G; Costa C; Sánchez MP; Serratosa JM
    Mol Ther; 2024 Jul; 32(7):2130-2149. PubMed ID: 38796707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphatase activity of laforin is dispensable to rescue Epm2a-/- mice from Lafora disease.
    Gayarre J; Duran-Trío L; Criado Garcia O; Aguado C; Juana-López L; Crespo I; Knecht E; Bovolenta P; Rodríguez de Córdoba S
    Brain; 2014 Mar; 137(Pt 3):806-18. PubMed ID: 24430976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial Effect of Fingolimod in a Lafora Disease Mouse Model by Preventing Reactive Astrogliosis-Derived Neuroinflammation and Brain Infiltration of T-lymphocytes.
    Rubio T; Campos-Rodríguez Á; Sanz P
    Mol Neurobiol; 2024 Jun; 61(6):3105-3120. PubMed ID: 37971656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model.
    Mollá B; Heredia M; Sanz P
    Mol Neurobiol; 2021 Jun; 58(6):2508-2522. PubMed ID: 33447969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.